Skip to content

Clinical trials

Hematologic Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: Netherlands Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20092
20121
20134
20143
20151
20172
20181
20192
20201
20213
20224
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting6
Recruiting3
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Abbott Medical Devices2
Agios Pharmaceuticals, Inc.2
CTI BioPharma2
Chroma Therapeutics2
Cogent Biosciences, Inc.2
Erasmus Medical Center2
Pfizer2
Takeda2
Ariad Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases28
Bone Marrow Diseases8
Anemia7
Myeloproliferative Disorders7
Leukemia6
Immune System Diseases5
Thrombocythemia, Essential5
Thrombocytopenia5
Hemorrhagic Disorders4
Leukemia, Myeloid4

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.